These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 22953635

  • 1. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A, Koc Y, Basturk T, Akgun AO, Sakaci T, Ahbap E.
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
    [Abstract] [Full Text] [Related]

  • 2. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Jul; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 4. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
    Hovind P, Tarnow L, Rossing P, Teerlink T, Stehouwer CD, Emeis JJ, Parving HH.
    Am J Kidney Dis; 2001 Dec; 38(6):1376-80. PubMed ID: 11728978
    [Abstract] [Full Text] [Related]

  • 5. Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes.
    Yokoyama H, Kanno S, Takahashi S, Yamada D, Honjo J, Saito K, Sone H, Haneda M.
    Nephrol Dial Transplant; 2011 Sep; 26(9):2924-30. PubMed ID: 21303964
    [Abstract] [Full Text] [Related]

  • 6. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S, Blohmé G, Sylvén C, Mulec H.
    Nephrol Dial Transplant; 1997 Sep; 12 Suppl 2():67-70. PubMed ID: 9269704
    [Abstract] [Full Text] [Related]

  • 7. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.
    Aso Y, Suganuma R, Wakabayashi S, Hara K, Nakano T, Suetsugu M, Matsumoto S, Nakamachi T, Takebayashi K, Morita K, Inukai T.
    Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961
    [Abstract] [Full Text] [Related]

  • 8. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC, Collaborative Study Group.
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [Abstract] [Full Text] [Related]

  • 9. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C, Roderick P, Harris S, Rogerson M.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
    Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T.
    Nephrology (Carlton); 2013 Aug; 18(8):563-8. PubMed ID: 23714217
    [Abstract] [Full Text] [Related]

  • 11. [Anemia in diabetic nephropathy: prevalence, clinical and pathophysiological aspects].
    Shestakova MV, Martynov SA, Il'in AV, Kniazeva AP, Shamkhalova MSh, Trubitsyna NP.
    Ter Arkh; 2008 Aug; 80(6):41-7. PubMed ID: 18655475
    [Abstract] [Full Text] [Related]

  • 12. The epidemiology of hemoglobin levels in patients with type 2 diabetes.
    Thomas MC, Tsalamandris C, MacIsaac RJ, Jerums G.
    Am J Kidney Dis; 2006 Oct; 48(4):537-45. PubMed ID: 16997049
    [Abstract] [Full Text] [Related]

  • 13. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M, Tarnow I, Michelson AD, Jorsal A, Frelinger AL, Parving HH, Rossing P, Tarnow L.
    Platelets; 2010 Oct; 21(7):525-32. PubMed ID: 20701458
    [Abstract] [Full Text] [Related]

  • 14. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G.
    Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of the factors related to glomerular filtration rate in type 2 diabetes without albuminuria].
    Lu XH, Feng L, Jiang YB, Zhou YF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov; 30(11):2502-4. PubMed ID: 21097417
    [Abstract] [Full Text] [Related]

  • 16. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 17. [Clinical features and risk factors of renal damage in elderly and non-elderly patients with type 2 diabetes mellitus].
    Huang H, Li H, Zheng FP, Lu WN, Dong XH, Ruan Y.
    Zhonghua Yi Xue Za Zhi; 2010 Apr 13; 90(14):967-71. PubMed ID: 20646646
    [Abstract] [Full Text] [Related]

  • 18. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV, Koshel' LV, Vagodin VA, Dedov II.
    Ter Arkh; 2006 Apr 13; 78(5):60-4. PubMed ID: 16889052
    [Abstract] [Full Text] [Related]

  • 19. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.
    Orth SR, Schroeder T, Ritz E, Ferrari P.
    Nephrol Dial Transplant; 2005 Nov 13; 20(11):2414-9. PubMed ID: 16046507
    [Abstract] [Full Text] [Related]

  • 20. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C, Morange S, Portugal H, Berland Y, Dussol B.
    Am J Kidney Dis; 2001 Aug 13; 38(2):310-6. PubMed ID: 11479157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.